CASR and gastroesophageal reflux disease: Moreover, the failure of PPI therapy may increase the psychological burden, establishing a vicious cycle.38 We found that Tojapride is clinically efficacious against GERD, fulfils unmet needs for PPI therapy and can inhibit CaSR‐mediated NLRP3 inflammasome activation.